UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
- Title
- The Interleukin‐4 Receptor–Associated Kinase Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial
- Creators
- Aaron Winkler - Pfizer Cambridge MassachusettsWeiyong Sun - Pfizer Cambridge MassachusettsSaurav De - The Feinstein Institute Manhasset New YorkAiping Jiao - Pfizer Cambridge MassachusettsM. Nusrat Sharif - Pfizer Cambridge MassachusettsPeter T Symanowicz - Pfizer Cambridge MassachusettsShruti Athale - Baylor Institute for Immunology Research Dallas TexasJulia H Shin - Pfizer Cambridge MassachusettsJu Wang - Pfizer Cambridge MassachusettsBruce A Jacobson - Pfizer Cambridge MassachusettsSimeon J Ramsey - Pfizer Cambridge MassachusettsKen Dower - Pfizer Cambridge MassachusettsTatyana Andreyeva - Pfizer Cambridge MassachusettsHeng Liu - Pfizer Cambridge MassachusettsMartin Hegen - Pfizer Cambridge MassachusettsBruce L Homer - Pfizer Cambridge MassachusettsJoanne Brodfuehrer - Pfizer Cambridge MassachusettsMera Tilley - Pfizer Cambridge MassachusettsSteven A Gilbert - Pfizer Cambridge MassachusettsSpencer I Danto - Pfizer Cambridge MassachusettsJean J Beebe - Pfizer Cambridge MassachusettsBetsy J Barnes - The Feinstein Institute Manhasset New YorkVirginia Pascual - Baylor Institute for Immunology Research Dallas TexasLih‐Ling Lin - Pfizer Cambridge MassachusettsIain Kilty - Pfizer Cambridge MassachusettsMargaret Fleming - Pfizer Cambridge MassachusettsVikram R Rao - Pfizer Cambridge Massachusetts
- Publication Details
- Arthritis & rheumatology (Hoboken, N.J.)
- Publisher
- Wiley
- Identifiers
- 9924050363901921
- Academic Unit
- Department of Biology
- Language
- English
- Resource Type
- Journal article